Clinical trial
Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study
NCT00217165 · Mclean Hospital, Other · Completed
Key facts
| NCT number | NCT00217165 |
|---|---|
| Title | Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study |
| Official title | Taurine as an Anti-manic Agent: a Double-blind Placebo-controlled Study. |
| Lead sponsor | Mclean Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Mania, Bipolar Depression |
| Intervention type | Drug |
| Interventions | taurine |
| Enrollment | 60 |
| Start date | Apr 1, 2005 |
| Primary completion | Jan 1, 2010 |
| Completion | Dec 1, 2011 |
| First posted | Sep 22, 2005 |
| Last update posted | Mar 1, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: